BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 28, 2003
View Archived Issues
SYM-2081 attenuates inflammatory hyperalgesia
Read More
KRN-5500 shows significant activity against CLL cells in vitro
Read More
VEGF Trap prevents blinding blood vessel growth in mice
Read More
Ghrelin could have therapeutic value in endotoxic shock
Read More
Reductions in NK-kappaB activation may improve the outcome for sepsis
Read More
Sepracor reports phase III Estorra data in elderly patients
Read More
Enbrel approved for inhibition of bone and joint damage in psoriatic arthritis patients
Read More
Estrogen receptor agonist as a potential new treatment for hot flush
Read More
Oxymorphazole: a potent antinociceptive agent in mice
Read More
LY-503430: a new neuroprotective agent with therapeutic potential in Parkinson's disease
Read More
Two series of rifamycin antibiotics patented by ActivBiotics scientists
Read More
Novel imaging agents for the diagnosis of AD developed at Amersham
Read More
New anti-herpesvirus DNA polymerase agents identified at Pharmacia
Read More
Guilford presents new DPP-IV inhibitors for Parkinson's disease and other neurological disorders
Read More
South African approval to begin phase I trial of HIVA.MVA
Read More
Phase IIa DB-289 malaria study completes first stage
Read More
EpiPen approved in Japan for anaphylaxis triggered by insect stings
Read More
Long-lasting tumor responses seen in phase II NHL study of pixantrone
Read More
NIH program to evaluate Maxheal for SARS
Read More
Health Canada accepts Bexxar under priority review
Read More
APF-112 set to enter phase II postsurgical pain relief study in September
Read More
RealArt HPA Coronavirus test CE marked
Read More
Leptin exerts cardiac antihypertrophic effects in mice independent of weight loss
Read More